Q4 2016 Holdings
Filed 2017-02-13 | 143 holdings | $260.1M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↑ | Shares | % Portfolio |
|---|---|---|---|---|---|
| AbbVie Inc.(ABBV) | Common | 00287Y109 | $10 | 156 | 0.0% |
| Zafgen, Inc. | Common | 98885E103 | $42 | 13,307 | 0.0% |
| Quorum Health Corporation | Common | 74909E106 | $172 | 23,725 | 0.0% |
| The RMR Group Inc.(RMR) | Class A | 74967R106 | $294 | 7,441 | 0.0% |
| Celldex Therapeutics, Inc. | Common | 15117B103 | $375 | 105,800 | 0.0% |
| Xencor, Inc.(XNCR) | Common | 98401F105 | $526 | 20,000 | 0.0% |
| Affimed NV | Common | N01045108 | $530 | 294,213 | 0.0% |
| Global Medical REIT Inc.(GMREUSD) | Common | 37954A204 | $655 | 73,400 | 0.0% |
| Novavax, Inc. | Common | 670002104 | $719 | 571,000 | 0.0% |
| Tetraphase Pharmaceuticals, Inc. | Common | 88165N105 | $775 | 192,322 | 0.0% |
| Bellicum Pharmaceuticals, Inc. | Common | 079481107 | $817 | 60,000 | 0.0% |
| Auris Medical Holding AG | Common | H03579101 | $829 | 774,504 | 0.0% |
| Flex Pharma, Inc. | Common | 33938A105 | $856 | 162,124 | 0.0% |
| Intellia Therapeutics, Inc.(NTLA) | Common | 45826J105 | $942 | 71,842 | 0.0% |
| Alliqua BioMedical, Inc. | Common | 019621200 | $974 | 1,650,000 | 0.0% |
| Juno Therapeutics, Inc. | Common | 48205A109 | $1.1K | 56,900 | 0.0% |
| TherapeuticsMD, Inc. | Common | 88338N107 | $1.1K | 187,100 | 0.0% |
| GenMark Diagnostics, Inc.(GNMK) | Common | 372309104 | $1.1K | 93,349 | 0.0% |
| Spark Therapeutics, Inc. | Common | 84652J103 | $1.2K | 24,300 | 0.0% |
| Esperion Therapeutics, Inc.(ESPR) | Common | 29664W105 | $1.3K | 102,800 | 0.0% |
| Healthcare Trust of America, Inc. | Class A | 42225P501 | $1.3K | 46,000 | 0.0% |
| uniQure N.V.(QURE) | Shares | N90064101 | $1.4K | 241,021 | 0.0% |
| HCP, Inc. | Common | 40414L109 | $1.4K | 45,500 | 0.0% |
| Dynavax Technologies Corporation(DVAX) | Common | 268158201 | $1.4K | 345,050 | 0.0% |
| Cidara Therapeutics, Inc. | Common | 171757107 | $1.4K | 132,472 | 0.0% |
| Acceleron Pharma, Inc.(XLRN) | Common | 00434H108 | $1.4K | 54,450 | 0.0% |
| Chimerix, Inc.(CMRXEUR) | Common | 16934W106 | $1.4K | 308,892 | 0.0% |
| Welltower Inc.(WELL) | Common | 95040Q104 | $1.4K | 21,400 | 0.0% |
| Diplomat Pharmacy, Inc.(DPLOEUR) | Common | 25456K101 | $1.6K | 130,223 | 0.0% |
| Impax Laboratories, Inc. | Common | 45256B101 | $1.6K | 124,335 | 0.0% |
| Achillion Pharmaceuticals, Inc.(ACHNEUR) | Common | 00448Q201 | $1.8K | 443,851 | 0.0% |
| Halozyme Therapeutics, Inc.(HALO) | Common | 40637H109 | $2.0K | 200,000 | 0.0% |
| Forward Pharma A/S | Sponsored ADR | 34986J105 | $2.1K | 136,547 | 0.0% |
| Healthcare Realty Trust, Inc. | Common | 421946104 | $2.1K | 68,000 | 0.0% |
| Amicus Therapeutics, Inc.(FOLD) | Common | 03152W109 | $2.1K | 418,730 | 0.0% |
| Nabriva Therapeutics AG | Sponsored ADR | 62957M104 | $2.1K | 350,000 | 0.0% |
| McKesson Corporation(MCK) | Common | 58155Q103 | $2.1K | 15,000 | 0.0% |
| Adamas Pharmaceuticals, Inc.(ADMSEUR) | Common | 00548A106 | $2.1K | 125,504 | 0.0% |
| Endologix, Inc. | Common | 29266S106 | $2.2K | 386,750 | 0.0% |
| DBV Technologies S.A. | Sponsored ADR | 23306J101 | $2.3K | 65,600 | 0.0% |
| Arca biopharma, Inc. | Common | 00211Y407 | $2.3K | 811,227 | 0.0% |
| Tenet Healthcare Corporation(THC) | Common | 88033G407 | $2.4K | 164,500 | 0.0% |
| Accelerate Diagnostics, Inc. | Common | 00430H102 | $2.5K | 120,000 | 0.0% |
| Horizon Pharma plc | Shares | G4617B105 | $2.6K | 162,900 | 0.0% |
| Grifols, S.A.(GRFS) | Sponsored ADR | 398438408 | $2.7K | 166,000 | 0.0% |
| Sage Therapeutics, Inc.(SG7) | Common | 78667J108 | $2.8K | 54,000 | 0.0% |
| Valeant Pharmaceuticals International, Inc. | Common | 91911K102 | $2.8K | 192,000 | 0.0% |
| bluebird bio, Inc. | Common | 09609G100 | $3.0K | 49,345 | 0.0% |
| Mallinckrodt plc | Shares | G5785G107 | $3.1K | 61,900 | 0.0% |
| Perrigo Company plc(PRGO) | Shares | G97822103 | $3.1K | 37,300 | 0.0% |